1 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00076
D00076
|
Norepinephrine
| [2] 22 22, 296 |
2 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00095
D00095
|
Epinephrine
| [3] 46 46, 70, 96 |
3 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00124
D00124
|
Ephedrine
| [1] 11 11 |
4 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00270
D00270
|
Chlorpromazine
| [1] 254 254 |
5 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00281
D00281
|
Clonidine
| [4] 6 6, 65, 70, 78 |
6 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00283
D00283
|
Clozapine
| [1] 6 6 |
7 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00514
D00514
|
Dexmedetomidine
| [14] 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 |
8 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00560
D00560
|
Pimozide
| [1] 2 2 |
9 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D01277
D01277
|
Droxidopa
| [5] 5 5, 6, 17, 169, 170 |
10 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D02349
D02349
|
Dipivefrin
| [1] 6 6 |
11 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D04375
D04375
|
Guanabenz
| [2] 2 2, 13 |
12 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D07461
D07461
|
Apraclonidine
| [1] 11 11 |
13 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D07540
D07540
|
Brimonidine
| [2] 13 13, 90 |
14 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08031
D08031
|
Guanfacine
| [1] 193 193 |
15 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08207
D08207
|
Methylergometrine
| [1] 280 280 |
16 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08449
D08449
|
Pseudoephedrine
| [1] 17 17 |
17 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08482
D08482
|
Rilmenidine
| [1] 8 8 |
18 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08611
D08611
|
Tizanidine
| [1] 13 13 |
19 |
ADRA2A
| [2] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08685
D08685
|
Yohimbine
| [1] 6 6 |